On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect
Year: 2014
Type: article
Abstract: under controlled environmental conditions allows for precise control over cell growth and protein production, batch-to-batch product consistency and a production process aligned with current good manufacturing practices. With the recent US FDA approval and commercialization of the world's first plant cell-based recombinant pharmaceutical for human use, β-glucocerebrosidase for treatment of Gaucher's disease, a new era has come in which plant cell culture shows high potential to displace some established platform technologies in niche markets. This review updates the progress in plant cell culture processing technology, highlights recent commercial successes and discusses the challenges that must be overcome to make this platform commercially viable.
Source: Pharmaceutical Bioprocessing
DOI: 10.4155/pbp.14.32
Authors: Jianfeng Xu, Ningning Zhang
Institutions: Arkansas State University, Arkansas Biosciences Institute
Language: English
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2160615881
